
Sign up to save your podcasts
Or
What strategies can reduce development time and accelerate access to next-generation monoclonal antibodies (mAbs) in the evolving SARS-CoV-2 variant landscape?
Credit available for this activity expires: 1/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999900?ecd=bdc_podcast_libsyn_mscpedu
4
77 ratings
What strategies can reduce development time and accelerate access to next-generation monoclonal antibodies (mAbs) in the evolving SARS-CoV-2 variant landscape?
Credit available for this activity expires: 1/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999900?ecd=bdc_podcast_libsyn_mscpedu
135 Listeners
13 Listeners
315 Listeners
107 Listeners
868 Listeners
249 Listeners
497 Listeners
688 Listeners
18 Listeners
278 Listeners
3,323 Listeners
1,103 Listeners
195 Listeners
516 Listeners
349 Listeners
61 Listeners
24 Listeners
427 Listeners
367 Listeners